Forte Biosciences, Inc. Revenue 2016–2019
Forte Biosciences, Inc. annual/quarterly revenue history and growth rate from 2016 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Forte Biosciences, Inc. revenue for the quarter ending September 30, 2019 was 9000, a 99.95% decrease year-over-year.
- Forte Biosciences, Inc. revenue for the twelve months ending September 30, 2019 was 18.0 M, a 47363.16% increase year-over-year.
- Forte Biosciences, Inc. annual revenue for 2019 was 36000, a 99.80% decrease from 2018.
- Forte Biosciences, Inc. annual revenue for 2018 was 18.0 M, a 43890.24% increase from 2017.
- Forte Biosciences, Inc. annual revenue for 2017 was 41000, a 16.33% decrease from 2016.
- Forte Biosciences, Inc. annual revenue for 2016 was 49000.
Forte Biosciences, Inc. (FBRX) — Frequently Asked Questions
Forte Biosciences, Inc. (FBRX) is a publicly traded US company. It has a market capitalization of $37M. In fiscal 2019 it reported revenue of $36,000 and net income of -$4M. Explore FBRX's stock price, financial statements, earnings history, margins and key ratios below.
What is Forte Biosciences, Inc.'s market cap?
Forte Biosciences, Inc. (FBRX) has a market capitalization of $37M.
What is the FBRX stock price?
FBRX trades at $17.40 (+3.45% on the day).
How much revenue does Forte Biosciences, Inc. make?
Forte Biosciences, Inc. reported revenue of $36,000 in fiscal 2019.
Is FBRX profitable?
In fiscal 2019, Forte Biosciences, Inc. reported net income of -$4M.